Tiverton Asset Management’s Quest Diagnostics DGX Stock Holding History

Tiverton Asset Management’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$1.32M	Buy	12,345 +6,128	+99%	+$629K	0.05%	259
2019 Q2	$633K	Buy	6,217 +1,638	+36%	+$157K	0.02%	335
2019 Q1	$411K	Hold	4,579	–	–	0.02%	383
2018 Q4	$381K	Hold	4,579	–	–	0.02%	253
2018 Q3	$494K	Buy	4,579 +2,450	+115%	+$269K	0.02%	248
2018 Q2	$234K	Sell	2,129 -91	-4%	-$9.48K	0.01%	301
2018 Q1	$223K	Buy	2,220 +61	+3%	+$6.25K	0.02%	301
2017 Q4	$213K	Buy	+2,159	New	+$205K	0.01%	353

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

FMI

Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

MWNA

Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return

Tiverton Asset Management's DGX Position: Q3 2019 in Review

Tiverton Asset Management increased its Quest Diagnostics (DGX) stake by 99% in Q3 2019, buying an estimated $629K and bringing the position to 12,345 shares worth $1.32M. The position accounts for 0.05% of the portfolio, ranked #259.

Tiverton Asset Management first reported a position in DGX in Q4 2017 and has held it in 8 quarters since. 676 funds tracked by Wall St. Rank hold DGX as of Q3 2019.

Tiverton Asset Management held 12,345 shares of Quest Diagnostics worth $1.32M as of Q3 2019.
Tiverton Asset Management bought 6,128 Quest Diagnostics shares in Q3 2019, an estimated $629K.
Quest Diagnostics made up 0.05% of Tiverton Asset Management's portfolio in Q3 2019, its #259 holding.
Tiverton Asset Management first reported a position in Quest Diagnostics in Q4 2017 and has held it in 8 quarters since.
676 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2019.

Based on Tiverton Asset Management's 13F filing for Q3 2019, filed 13 Nov 2019.